You searched for Humanized antibody - Page 12 of 44

News and Trends 11 Dec 2017

Belgian Antibody Proves Effective to Treat Myasthenia Gravis

…Phase II trial with ARGX-113 (efgartigimod), in which the antibody therapy has proved to provide a significant improvement in patients with generalized myasthenia gravis, a form of the disease that…

December 11, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 8 Aug 2022

Genmab and BioNTech expand collaboration to develop and commercialize immunotherapy candidates

…with our colleagues at Genmab to develop new treatments for people affected by cancer.” GEN1053/BNT313 is a CD27 antibody based on the HexaBody technology, specifically engineered to form an antibody…

August 8, 2022 - 2 minutesmins - By Liza Laws

News and Trends 6 Jul 2017

Roche and Ireland’s Biggest Biopharma Take Their Parkinson’s Antibody to Phase II

Prothena and Roche are advancing their Parkinson’s antibody to Phase II, triggering a new milestone payment from what is proving a lucrative deal for Prothena. Prothena, the largest biopharma in…

July 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 26 Jul 2024

Confo Therapeutics raises $60 million to focus on agonistic GPCR antibodies

…said Ververken. The company’s approach revolves around its ConfoBodies, conformation-specific llama-derived antibody fragments (VHHs), which “promote GPCRs into functionally relevant states,” as Ververken put it. “ConfoBodies are used in our…

July 26, 2024 - 8 minutesmins - By Jules Adam

News and Trends 4 Apr 2023

BioNTech adds antibody-drug conjugates to cancer portfolio with potential $1.5B partnership deal

BioNTech SE and Duality Biologics (Suzhou) Co. Ltd. have entered into exclusive license and collaboration agreements for two antibody-drug conjugate (ADC) assets to develop, manufacture and commercialize the two assets…

April 4, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 3 May 2022

Tubulis Rides Investment Wave in ADCs with €60M Series B

…drug-to-antibody ratio as well as the linker chemistry of the ADC,” said Schumacher. For example, ADCs with very toxic payloads should pack fewer molecules per antibody, whereas candidates with milder…

May 3, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 4 Jun 2025

ASCO 2025: key highlights in cancer therapeutics

…on immunotherapies, cell and gene therapies, and antibody-drug conjugates (ADCs) whereas about 10% of the content was focused on traditional modalities of chemotherapy, radiation, and surgery, according to Musaddiq Khan,…

June 4, 2025 - 18 minutesmins - By Roohi Mariam Peter

In Depth 17 Oct 2017

Blockbuster Potential: How Biotech is Paving the Way to Clear Skin from Psoriasis

…series of phase III trials with the antibody for psoriatic arthritis, as well as another head-to-head study with the anti-IL-17 antibody, Cosentyx. Boehringer Ingelheim and AbbVie have partnered to develop…

October 17, 2017 - 7 minutesmins - By Diana Kwon

News and Trends 11 Jun 2020

AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal

…sales milestones. The two companies will jointly develop and commercialize three of Genmab’s anti-cancer antibody drugs, which are currently in phase I trials. Genmab’s antibody drugs — which are able…

June 11, 2020 - 3 minutesmins - By External Contributor

News and Trends 17 Oct 2019

Innate Pharma Raises €62M IPO to Develop Antibody Drugs for Cancer

The French company Innate Pharma has raised a Nasdaq IPO of €62.1M ($68.8M) to fund the development of antibody immunotherapies for solid tumors and blood cancer. Innate Pharma’s lead candidate…

October 17, 2019 - 2 minutesmins - By Jonathan Smith

abcam axiomx acquisition milestone antibody

More News! 18 May 2017

Abcam Makes Final Payment in the Acquisition of an US Antibody Biotech

Abcam has paid US-based AxioMx a final €4.5M milestone based on performance, completing an acquisition that totals €36.4M. Giant antibody maker Abcam, founded by star biotech entrepreneur Jonathan Milner and…

May 18, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 2 Apr 2025

Top biotech deals of March 2025

…was approved by the U.S. Food and Drug Administration (FDA) to treat multiple myeloma in 2021. Meanwhile, French pharmaceutical company Sanofi has acquired California-based antibody developer Dren Bio’s bispecific myeloid…

April 2, 2025 - 9 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Belgian Antibody Proves Effective to Treat Myasthenia Gravis

Genmab and BioNTech expand collaboration to develop and commercialize immunotherapy candidates

Roche and Ireland’s Biggest Biopharma Take Their Parkinson’s Antibody to Phase II

Confo Therapeutics raises $60 million to focus on agonistic GPCR antibodies

BioNTech adds antibody-drug conjugates to cancer portfolio with potential $1.5B partnership deal

Tubulis Rides Investment Wave in ADCs with €60M Series B

ASCO 2025: key highlights in cancer therapeutics

Blockbuster Potential: How Biotech is Paving the Way to Clear Skin from Psoriasis

AbbVie and Genmab Strike €3.4B Immuno-Oncology Megadeal

Innate Pharma Raises €62M IPO to Develop Antibody Drugs for Cancer

Abcam Makes Final Payment in the Acquisition of an US Antibody Biotech

Top biotech deals of March 2025

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!